Lunit Inc
328130
Company Profile
Business description
Lunit Inc is a medical AI software company devoted to providing AI-powered total cancer care. Its products comprise of Lunit INSIGHT CXR, AI solution for Chest x-ray; Lunit INSIGHT MMG, AI solution for Mammography; Lunit SCOPE IO, AI-Powered Biomarker for Immuno-Oncology; and Lunit SCOPE PD-L1, AI Solution for PD-L1 Expression.
Contact
374 Gangnam-daero
4th to 9th Floors, Case Square Gangnam II
Yeoksam-dong, Gangnam-gu
Seoul06241
KORT: +82 221380827
Sector
Healthcare
Stock type
Defensive
Industry
Health Information Services
Fiscal Year End
31 December 2026
Employees
312
Stocks News & Analysis
stocks
Wide moat stock exchange remains cheap
Aussie stock exchange remains materially undervalued despite growing cost concerns.
stocks
ASX data center player expands pipeline but questions remain
Questions surround Australia’s largest data center developer and its growing pipeline.
stocks
Cheap e-commerce share continues sales momentum
The e-commerce business continues its sales momentum despite challenging backdrop.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,965.00 | 77.80 | 0.88% |
| CAC 40 | 8,204.73 | 15.86 | 0.19% |
| DAX 40 | 25,065.21 | 27.04 | -0.11% |
| Dow JONES (US) | 50,889.54 | 220.57 | 0.44% |
| FTSE 100 | 10,417.48 | 8.48 | -0.08% |
| HKSE | 25,182.39 | 176.23 | 0.70% |
| NASDAQ | 27,013.79 | 96.32 | 0.36% |
| Nikkei 225 | 66,329.50 | 1,636.38 | 2.53% |
| NZX 50 Index | 13,244.55 | 38.44 | 0.29% |
| S&P 500 | 7,590.12 | 26.49 | 0.35% |
| S&P/ASX 200 | 8,731.70 | 73.10 | 0.84% |
| SSE Composite Index | 4,068.57 | 30.07 | -0.73% |